1. #link("https://livermetabolism.com/paper/Elias2025_frontiers.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/glimepiride-model")[#fa-icon("git-alt")] *A Digital Twin of Glimepiride for Personalized and Stratified Diabetes Treatment*. Michelle Elias, *Matthias König*; Front. Pharmacol. 16:1686415., #link("https://doi.org/10.3389/fphar.2025.1686415")[10.3389/fphar.2025.1686415], IF: *4.8*, #underline[Last Author]
2. #link("https://livermetabolism.com/paper/Albadry2024_species_comparison.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/zonation-image-analysis")[#fa-icon("git-alt")] *Cross-Species Variability in Lobular Geometry and Cytochrome P450 Hepatic Zonation: Insights into CYP1A2, CYP2E1, CYP2D6 and CYP3A4*. Mohamed Albadry, Jonas Kuettner, Jan Grzegorzewski, Olaf Dirsch, Eva Kindler, Robert Klopfleisch, Vaclav Liska, Vladimira Moulisova, Sandra Nickel, Richard Palek, Jachym Rosendorf, Sylvia Saalfeld, Utz Settmacher, Hans-Michael Tautenhahn, *Matthias KönigΔ*, Uta DahmenΔ (Δ equal contribution); Front Pharmacol. 2024 May 16;15:1404938, #link("https://doi.org/10.3389/fphar.2024.1404938")[10.3389/fphar.2024.1404938], IF: *5.4*, #underline[Last Equal Author]
3. #link("https://livermetabolism.com/paper/Smith2024_SED-ML_L1V5.pdf")[#fa-icon("file-pdf")]#link("https://github.com/SED-ML/sed-ml")[#fa-icon("git-alt")] *The simulation experiment description markup language (SED-ML): language specification for level 1 version 5*. Smith LP, Bergmann FT, Garny A, Helikar T, Karr J, Nickerson D, Sauro H, Waltemath D, *König M.*; J Integr Bioinform. 2024 Apr 15, #link("https://doi.org/10.1515/jib-2024-0008")[10.1515/jib-2024-0008], IF: *1.5*, #underline[Last Author]
4. #link("https://livermetabolism.com/paper/Maheshvare2023_pancreas.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/pancreas-model")[#fa-icon("git-alt")] *A pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell*. Maheshvare MD., Raha S., *König M.Δ*, and Pal D.Δ (Δ equal contribution); Front. Endocrinol. 14:1185656, #link("https://doi.org/10.3389/fendo.2023.1185656")[10.3389/fendo.2023.1185656], IF: *5.7*, #underline[Last Equal Author]
5. #link("https://livermetabolism.com/paper/Grzegorzewski2022_dextromethorphan.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/dextromethorphan-model")[#fa-icon("git-alt")] *Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan*. Grzegorzewski, J., Brandhorst, J., *König, M.*; Front Pharmacol. 2022 Oct 24;13:1029073, #link("https://doi.org/10.3389/fphar.2022.1029073")[10.3389/fphar.2022.1029073], IF: *4.4*, #underline[Last Author]
6. #link("https://livermetabolism.com/paper/Caffeine_meta_Grzegorzewski2021.pdf")[#fa-icon("file-pdf")] *Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing*. Jan Grzegorzewski, Florian Bartsch, Adrian Köller, and *Matthias König*; Frontiers in Pharmacology 2022, Vol12, #link("https://doi.org/10.3389/fphar.2021.752826")[10.3389/fphar.2021.752826], IF: *4.4*, #underline[Last Author]
7. #link("https://livermetabolism.com/paper/ICG_model_hepatectomy_Koeller2021.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/icg-model.git")[#fa-icon("git-alt")] *Prediction of survival after hepatectomy using a physiologically based pharmacokinetic model of indocyanine green liver function tests*. Adrian Köller, Jan Grzegorzewski, Michael Tautenhahn, *Matthias König*; Front. Physiol., 22 November 2021, #link("https://doi.org/10.3389/fphys.2021.730418")[10.3389/fphys.2021.730418], IF: *3.2*, #underline[Last Author]
8. #link("https://livermetabolism.com/paper/Koeller2021_icg_variability.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/icg-model")[#fa-icon("git-alt")] *Physiologically based modeling of the effect of physiological and anthropometric variability on indocyanine green based liver function tests*. Adrian Köller, Jan Grzegorzewski and *Matthias König*; Front Physiol. 2021 Nov 22;12:757293, #link("https://doi.org/10.3389/fphys.2021.757293")[10.3389/fphys.2021.757293], IF: *3.2*, #underline[Last Author]
9. #link("https://livermetabolism.com/paper/PKDB_Grzegorzewski2020.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/pkdb")[#fa-icon("git-alt")] *PK-DB: pharmacokinetics database for individualized and stratified computational modeling*. Grzegorzewski J, Brandhorst J, Green K, Eleftheriadou D, Duport Y, Barthorscht F, Köller A, Ke DYJ, De Angelis S, *König M.*; Nucleic Acids Res. 2021 Jan 8;49(D1):D1358-D1364, #link("https://doi.org/10.1093/nar/gkaa990")[10.1093/nar/gkaa990], IF: *16.7*, #underline[Last Author]
10. #link("https://livermetabolism.com/paper/SBML_Keating2019.pdf")[#fa-icon("file-pdf")]#link("https://sourceforge.net/projects/sbml/")[#fa-icon("git-alt")] *SBML Level 3: an extensible format for the exchange and reuse of biological models*. SM Keating, D Waltemath, *M König*, F Zhang, A Dräger, C Chaouiya, FT Bergmann, A Finney, CS Gillespie, T Helikar, S Hoops, RS Malik-Sheriff, SL Moodie, II Moraru, CJ Myers, A Naldi, BG Olivier, S Sahle, JC Schaff, LP Smith, MJ Swat, DT, L Watanabe, DJ Wilkinson, ML Blinov, K Begley, JR Faeder, HF Gómez, TM Hamm, Y Inagaki, W Liebermeister, AL Lister, D Lucio, E Mjolsness, CJ Proctor, K Raman, N Rodriguez, CA Shaffer, BE Shapiro, J Stelling, N Swainston, N Tanimura, J Wagner, M Meier-Schellersheim, HM Sauro, B Palsson, H Bolouri, H Kitano, Akira Funahashi, H Hermjakob, JC Doyle M Hucka, and SBML Community members; Mol Syst Biol. 2020;16(8):e9110, #link("https://doi.org/10.15252/msb.20199110")[10.15252/msb.20199110], IF: *8.8*
